(Q39464499)

12 September 2017

1 reference

title

The effects of beta-adrenergic blocking agents on blood lipid levels (English)

1 reference

12 September 2017

Wolinsky H

1

1 reference

12 September 2017

publication date

1 October 1987

1 reference

12 September 2017

1 reference

12 September 2017

volume

10

1 reference

12 September 2017

issue

10

1 reference

12 September 2017

page(s)

561-566

1 reference

HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

Long-term Effect of Sotalol on Plasma Lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

Antihypertensive drugs and blood lipids: the Oslo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

Propranolol and hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Adrenergic mechanisms in control of plasma lipid concentrations

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Metabolic consequences of atenolol and propranolol in treatment of essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Serum lipoprotein changes during atenolol treatment of essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

The effect of metoprolol and atenolol on plasma high density lipoprotein levels in man

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Effects of alpha-adrenergic and beta-adrenergic receptor blockade on lipid metabolism.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Effects of long-term practolol therapy on plasma-lipids after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Treatment of mild hypertension: a five year controlled drug trial. The Oslo study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Further analyses of the hypertension detection and follow-up program

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Effects of beta-blockers on plasma lipids during antihypertensive therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Effect of propranolol and prazosin on blood lipids. The Oslo Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Effects of prazosin and propranolol on serum lipids in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

https://api.crossref.org/works/10.1002%2FCLC.4960101010

1 reference

7 January 2021

Serum lipoproteins during antihypertensive therapy with beta blockers and diuretics: a controlled long-term comparative trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Effects of Labetalol on lipid and carbohydrate metabolism

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Studies on the effects of propranolol on plasma catecholamine levels in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Effects of antihypertensive therapy on blood lipid levels

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Comparative effects of prazosin and atenolol on plasma lipids in hypertensive patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Adrenergic effects on plasma lipoprotein metabolism. Speculation on mechanisms of action

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Pathogenesis and management of lipoprotein disorders

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Beta-blockers and plasma triglycerides.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Effect of chronic administration of propranolol on lipoprotein composition

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Metabolic effects of beta-adrenoreceptor blockers

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Effects of antihypertensive therapy on serum lipoproteins

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Antihypertensive therapy and lipids. Evidence, mechanisms, and implications

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960101010

7 January 2021

Identifiers

DOI

10.1002/CLC.4960101010

1 reference

12 September 2017

1 reference